Navidea Biopharmaceuticals Inc (NAVB)
0.0381
0.00 (0.00%)
USD |
OTCM |
Apr 26, 13:29
Navidea Biopharmaceuticals Cash from Financing (TTM): 0.9958M for Sept. 30, 2023
Cash from Financing (TTM) Chart
Historical Cash from Financing (TTM) Data
Date | Value |
---|---|
September 30, 2023 | 0.9958M |
June 30, 2023 | 7.394M |
March 31, 2023 | 7.281M |
December 31, 2022 | 7.142M |
September 30, 2022 | 7.114M |
June 30, 2022 | 3.112M |
March 31, 2022 | 3.802M |
December 31, 2021 | 12.11M |
September 30, 2021 | 13.82M |
June 30, 2021 | 16.56M |
March 31, 2021 | 17.61M |
December 31, 2020 | 10.21M |
September 30, 2020 | 9.620M |
June 30, 2020 | 4.596M |
March 31, 2020 | 6.792M |
December 31, 2019 | 6.156M |
September 30, 2019 | 5.081M |
June 30, 2019 | 8.081M |
March 31, 2019 | -4.497M |
December 31, 2018 | -4.548M |
September 30, 2018 | -4.531M |
June 30, 2018 | -7.496M |
March 31, 2018 | -0.3549M |
December 31, 2017 | -61.00M |
September 30, 2017 | -62.46M |
Date | Value |
---|---|
June 30, 2017 | -65.42M |
March 31, 2017 | -69.90M |
December 31, 2016 | -9.144M |
September 30, 2016 | -7.616M |
June 30, 2016 | -4.944M |
March 31, 2016 | 17.29M |
December 31, 2015 | 20.79M |
September 30, 2015 | 20.74M |
June 30, 2015 | 21.06M |
March 31, 2015 | 3.459M |
December 31, 2014 | 3.192M |
September 30, 2014 | 3.210M |
June 30, 2014 | 32.01M |
March 31, 2014 | 55.48M |
December 31, 2013 | 60.72M |
September 30, 2013 | 66.04M |
June 30, 2013 | 36.80M |
March 31, 2013 | 13.56M |
December 31, 2012 | 5.070M |
September 30, 2012 | 6.323M |
June 30, 2012 | 7.511M |
March 31, 2012 | 5.933M |
December 31, 2011 | 11.08M |
September 30, 2011 | 9.986M |
June 30, 2011 | 9.151M |
Cash From Financing Definition
Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.
Cash from Financing (TTM) Range, Past 5 Years
0.9958M
Minimum
Sep 2023
17.61M
Maximum
Mar 2021
8.193M
Average
7.211M
Median
Cash from Financing (TTM) Benchmarks
Perspective Therapeutics Inc | 0.785M |
Electromed Inc | -0.128M |
Xtant Medical Holdings Inc | 19.69M |
Asensus Surgical Inc | 9.626M |
Senseonics Holdings Inc | 20.37M |